Clinical Trial Update: Living With Sickle Cell Disease in the COVID-19 Pandemic

View source ↗

Summary

This clinical trial update reports on a completed study sponsored by NHGRI evaluating the experiences of people with sickle cell disease during the COVID-19 pan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Isolation, Anxiety | Status: COMPLETED